Logo-apb

Read This Article

Article History

Submitted: 10 Jun 2024
Accepted: 01 Oct 2024
ePublished: 02 Oct 2024

  Google Scholar Profile

PubMed Profile

Share This Article!

Export Citation

EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Cited By

Adv Pharm Bull. 2024;14(4): 714-715.
doi: 10.34172/apb.43269
PMID: 40190684
PMCID: PMC11970488
  Abstract View: 1071
  PDF Download: 842
  Full Text View: 377

Letter to Editor

Biological Therapies in Oncology: Balancing Efficacy and Safety in the Context of Latent Tuberculosis

Maher Monir. Akl 1* ORCID logo, Amr Ahmed 2 ORCID logo

1 Department of Chemistry, Faculty of Science, Mansoura University, 35516, Mansoura, Egypt.
2 The Public Health Department, Riyadh First Health Cluster, Ministry of Health, Saudia Arabia.
*Corresponding Author: Maher Monir. Akl, Email: maherakl555@gmail.com
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 1072

Your browser does not support the canvas element.

PDF Download: 842

Your browser does not support the canvas element.

Full Text View: 377

Your browser does not support the canvas element.